Religare Pharma Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 2.44 Cr
- Company Age 20 Year, 6 Months
- Last Filing with ROC 31 Mar 2013
- Open Charges ₹ 8.55 Cr
About Religare Pharma
Religare Pharma Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 August 2004 and has a history of 20 years and six months. Its registered office is in Dist-Nashik, Maharashtra.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2013. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.44 Cr.
The company currently has active open charges totaling ₹8.55 Cr.
Alok Munim and Bharat Munim serve as directors at the Company.
Company Details
- Location Dist-Nashik, Maharashtra
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24230MH2004PTC147950
-
Company No.
147950
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Aug 2004
-
Date of AGM
30 Sep 2013
-
Date of Balance Sheet
31 Mar 2013
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Religare Pharma Private Limited offer?
Religare Pharma Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Sexual Wellness Products, Erectile Dysfunction Medicine, Pharma Ingredients & Raw Materials, API (Active Pharmaceutical Ingredients), Injectable Products, Nervous System and Antipsychotic API.
Who are the key members and board of directors at Religare Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alok Munim
|
Director | 12-Aug-2004 | Current |
|
Bharat Munim
|
Director | 12-Aug-2004 | Current |
Financial Performance of Religare Pharma.
Enhance accessibility to Religare Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Religare Pharma?
Unlock access to Religare Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹8.55 Cr
₹0
Charges Breakdown by Lending Institutions
- Small Industries Development Bank Of India : 7.60 Cr
- Bank Of Maharashtra : 0.95 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Mar 2012 | Small Industries Development Bank Of India | ₹1.00 Cr | Open |
| 13 Mar 2012 | Bank Of Maharashtra | ₹9.50 M | Open |
| 30 Mar 2009 | Small Industries Development Bank Of India | ₹5.00 M | Open |
| 29 Dec 2008 | Small Industries Development Bank Of India | ₹5.00 M | Open |
| 29 Dec 2008 | Small Industries Development Bank Of India | ₹9.00 M | Open |
How Many Employees Work at Religare Pharma?
Religare Pharma has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Religare Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Religare Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.